Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon

This publication has 12 references indexed in Scilit:

• Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FU
  Acta Oncologica, 1987
• Treatment of the Malignant Carcinoid Syndrome
  New England Journal of Medicine, 1986
• Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon Alpha_Ain Chronic Myelogenous Leukemia
  New England Journal of Medicine, 1986
• Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
  Gut, 1985
• Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia
  New England Journal of Medicine, 1984
• Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome
  New England Journal of Medicine, 1983
• Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma
  Blood, 1981
• Simple and rapid determination of 5-hydroxyindole-3-acetic acid in urine by direct injection on a liquid chromatographic column
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1981
• Large-scale Production of Human Leukocyte Interferon Containing 108 Units per ml
  Journal of General Virology, 1978
• Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)
  Cancer, 1974